Author

Y. S. Yip

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Organism:chicken / avian· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

N. S. TAN· 2 shared W. R. TAN· 2 shared A. Franco-Obregon· 1 shared A. P. F. Koh· 1 shared A. S. NG· 1 shared A. WEE· 1 shared B. MICKELSON· 1 shared C. BALL· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

N. S. TAN

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Angiopoietin-like 4 shapes the intrahepatic T-cell landscape via eIF2α signalingduring steatohepatitis in diet-induced NAFLD.

Z. S. LOW, D. CHUA, H. S. CHENG, R. TEE, W. R. TAN, C. BALL, N. B. E. SAHIB, S. S. NG, J. QU, Y. LIU, H. HONG, C. CAI, N. C. L. RAO, A. WEE, M. D. MUTHIAH, , W. WAHLI

The paper identifies Angptl4's role in shaping intrahepatic T-cell activation via eIF2α signaling during fibrosis in diet-induced NAFLD.

bioRxiv · Jan 10, 2023 · PreprintImmunology

Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: segue towards a precision medicine approach.

Y. K. Tai, K. K. W. Chan, C. H. H. Fong, S. Ramanan, J. L. Y. Yap, J. N. Yin, Y. S. Yip, W. R. Tan, A. P. F. Koh, N. S. Tan, C. W. Chan, R. Y. J. Huang, A. Franco-Obregon

This study shows TRPC1 expression predicts breast cancer sensitivity to doxorubicin and PEMF therapy, suggesting TRPC1 as a biomarker for precision medicine approaches.

Frontiers in Oncology · Jan 24, 2022Peer-reviewedCancer Biology